enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Glioblastoma - Wikipedia

    en.wikipedia.org/wiki/Glioblastoma

    Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival. [ 6 ] [ 7 ] [ 8 ] Initial signs and symptoms of glioblastoma are nonspecific. [ 1 ]

  3. List of cancer mortality rates in the United States - Wikipedia

    en.wikipedia.org/wiki/List_of_cancer_mortality...

    In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.

  4. Cancer survival rates - Wikipedia

    en.wikipedia.org/wiki/Cancer_survival_rates

    The American Cancer Society reports 5-year relative survival rates of over 70% for women with stage 0-III breast cancer with a 5-year relative survival rate close to 100% for women with stage 0 or stage I breast cancer. The 5-year relative survival rate drops to 22% for women with stage IV breast cancer. [3]

  5. Gliosarcoma - Wikipedia

    en.wikipedia.org/wiki/Gliosarcoma

    Gliosarcoma is a malignant cancer, and is defined as a glioblastoma consisting of gliomatous and sarcomatous components. [3] Primary gliosarcoma (PGS) is classified as a grade IV tumor and a subtype of glioblastoma multiforme in the 2007 World Health Organization classification system (GBM). [ 4 ]

  6. Chronic myelogenous leukemia - Wikipedia

    en.wikipedia.org/wiki/Chronic_myelogenous_leukemia

    Before the advent of tyrosine kinase inhibitors, the median survival time for CML patients had been about 3–5 years from time of diagnosis. [3] With the use of tyrosine kinase inhibitors, survival rates have improved dramatically. A 2006 follow-up of 553 patients using imatinib (Gleevec) found an overall survival rate of 89% after five years ...

  7. Imatinib - Wikipedia

    en.wikipedia.org/wiki/Imatinib

    Due in part to the development of imatinib and related drugs, the five-year survival rate for people with chronic myeloid leukemia increased from 31% in 1993, to 59% in 2009, [13] to 70% in 2016. [14] By 2023, the five year survival rate for people with chronic myeloid leukemia had risen to 90%. [15]

  8. Spinal tumor - Wikipedia

    en.wikipedia.org/wiki/Spinal_tumor

    Most symptoms from spinal tumors occur due to compression of the spinal cord as it plays a primary role in motor and sensory function. [13] The spinal cord is surrounded by three layers known as the spinal meninges. [13] These are the dura mater, arachnoid mater, and pia mater. Spinal cord tumors are classified based on their location within ...

  9. Survival rate - Wikipedia

    en.wikipedia.org/wiki/Survival_rate

    Survival rate is a part of survival analysis.It is the proportion of people in a study or treatment group still alive at a given period of time after diagnosis. It is a method of describing prognosis in certain disease conditions, and can be used for the assessment of standards of therapy.